[Supraglottic and glottic carcinomas. Study of the incidence in the last 31 years]
- PMID: 18082073
[Supraglottic and glottic carcinomas. Study of the incidence in the last 31 years]
Abstract
Introduction: Laryngeal carcinoma is a common neoplasia in our country. It is well-known that the supraglottis is more frequently involved in Mediterranean countries. We present our results on the incidence of neoplasias affecting supraglottis and glottis and we find a change in the normal trend.
Objective: To study the incidence of glottic and supraglottic tumours in our hospital over the last 31 years. We also analyze risk factors such as smoking and alcohol in the population of the Valencian Region.
Patients and method: We performed a retrospective review of 991 patients diagnosed as having carcinomas of the glottis and supraglottis between 1974 and 2005. The epidemiological data about the consumption of tobacco and alcohol in the population of the Valencian Region, Spain, are obtained from descriptive epidemiological studies (Health Statistics and the 2003 National Health Survey).
Conclusions: With a total of 548 carcinomas of the glottis and 443 of the supraglottis, we find a change in the incidence maintained since 1990, with statistically significant differences (P=.0056). Thus, we can state that the glottis is more frequently affected than the supraglottis. Changes in the consumption of tobacco and alcohol cannot explain this current change.
Similar articles
-
Contribution of tobacco and alcohol to the high rates of squamous cell carcinoma of the supraglottis and glottis in Central Europe.Am J Epidemiol. 2007 Apr 1;165(7):814-20. doi: 10.1093/aje/kwk066. Epub 2007 Jan 22. Am J Epidemiol. 2007. PMID: 17244634
-
Influence of tobacco on laryngeal carcinoma in Spain.Neoplasma. 1992;39(5):319-22. Neoplasma. 1992. PMID: 1436247
-
Epidemiological Study of Laryngeal Carcinoma in Western Nepal.Asian Pac J Cancer Prev. 2015;16(15):6541-4. doi: 10.7314/apjcp.2015.16.15.6541. Asian Pac J Cancer Prev. 2015. PMID: 26434871
-
Alcohol consumption and risk of laryngeal cancer.Oral Oncol. 2005 Nov;41(10):956-65. doi: 10.1016/j.oraloncology.2005.02.004. Epub 2005 May 31. Oral Oncol. 2005. PMID: 15927525 Review.
-
Alcohol and laryngeal cancer: an update.Eur J Cancer Prev. 2008 Apr;17(2):116-24. doi: 10.1097/CEJ.0b013e3282b6fd40. Eur J Cancer Prev. 2008. PMID: 18287868 Review.
Cited by
-
In vitro and in vivo effect of 5-FC combined gene therapy with TNF-α and CD suicide gene on human laryngeal carcinoma cell line Hep-2.PLoS One. 2013 Apr 11;8(4):e61136. doi: 10.1371/journal.pone.0061136. Print 2013. PLoS One. 2013. PMID: 23593411 Free PMC article.
-
Differential beta-catenin expression between glottic and supraglottic laryngeal carcinoma.Eur Arch Otorhinolaryngol. 2010 Oct;267(10):1573-8. doi: 10.1007/s00405-010-1249-4. Epub 2010 Apr 18. Eur Arch Otorhinolaryngol. 2010. PMID: 20401664
-
mTOR inhibitor AZD8055 inhibits proliferation and induces apoptosis in laryngeal carcinoma.Int J Clin Exp Med. 2014 Feb 15;7(2):337-47. eCollection 2014. Int J Clin Exp Med. 2014. PMID: 24600487 Free PMC article.
-
Laryngeal cancer survival in Zaragoza (Spain): a population-based study.Clin Transl Oncol. 2012 Mar;14(3):221-4. doi: 10.1007/s12094-012-0787-1. Clin Transl Oncol. 2012. PMID: 22374426
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources